What is the efficacy of combination regimens in the treatment of metastatic colon cancer?

Updated: Apr 15, 2020
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print
Answer

Combination regimens provide improved efficacy and prolonged progression-free survival (PFS) in patients with metastatic colon cancer. The advent of new classes of active drugs and biologics for colorectal cancer has improved the expected survival for patients with metastatic disease. 


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!